Literature DB >> 12959318

The personality structure of 'normal' volunteers.

C J Ball1, P M McLaren, P J Morrison.   

Abstract

The personality structure of 65 volunteers for a Phase 1 drug trial was examined using the Eysenck Personality Questionnaire. It revealed a common pattern of high extroversion, low neuroticism and psychoticism. The reasons why the study might attract such people are examined and the structure compared with those that take drugs that might have 'strange or dangerous effects'. The likely forms of bias that this personality structure may bring to the trial are explored.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 12959318      PMCID: PMC1364693          DOI: 10.1111/j.1365-2125.1993.tb00379.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  12 in total

1.  Extraversion and variety-seeking in a monotonous task.

Authors:  A B Hill
Journal:  Br J Psychol       Date:  1975-02

2.  Clinical profiles of paid normal subjects volunteering for hallucinogen drug studies.

Authors:  H ESECOVER; S MALITZ; B WILKENS
Journal:  Am J Psychiatry       Date:  1961-04       Impact factor: 18.112

3.  The volunteer subject in research.

Authors:  L LASAGNA; J M VON FELSINGER
Journal:  Science       Date:  1954-09-03       Impact factor: 47.728

4.  Extraversion and preferred level of sensory stimulation.

Authors:  E J Ludvigh; D Happ
Journal:  Br J Psychol       Date:  1974-08

5.  Psychiatric assessment of 30 chronic users of cannabis and 30 matched controls.

Authors:  M H Beaubrun; F Knight
Journal:  Am J Psychiatry       Date:  1973-03       Impact factor: 18.112

6.  Motivations and rewards for volunteering to be an experimental subject.

Authors:  F J Ayd; P Calabresi
Journal:  Clin Pharmacol Ther       Date:  1972 Sep-Oct       Impact factor: 6.875

7.  Personality and sexual adjustment.

Authors:  H J Eysenck
Journal:  Br J Psychiatry       Date:  1971-06       Impact factor: 9.319

8.  Symptomatic volunteers in depression research: a closer look.

Authors:  M E Thase; C G Last; M Hersen; A S Bellack; J M Himmelhoch
Journal:  Psychiatry Res       Date:  1984-01       Impact factor: 3.222

9.  Psychiatric diagnoses (Research Diagnostic Criteria) in symptomatic volunteers.

Authors:  J Barrett
Journal:  Arch Gen Psychiatry       Date:  1981-02

10.  Do volunteer subjects bias clinical trials?

Authors:  G Amori; R H Lenox
Journal:  J Clin Psychopharmacol       Date:  1989-10       Impact factor: 3.153

View more
  8 in total

1.  Sensation seeking amongst healthy volunteers participating in phase I clinical trials.

Authors:  M Farré; X Lamas; J Camí
Journal:  Br J Clin Pharmacol       Date:  1995-04       Impact factor: 4.335

2.  The healthy volunteer in clinical pharmacology: personality and motivation.

Authors:  F P Meyer; R Haschke; F W Röhl
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

3.  Influence of the behaviour pattern on the nocebo response of healthy volunteers.

Authors:  M D Drici; F Raybaud; C De Lunardo; P Iacono; P Gustovic
Journal:  Br J Clin Pharmacol       Date:  1995-02       Impact factor: 4.335

4.  The placebo effect in healthy volunteers: influence of experimental conditions on physiological parameters during phase I studies.

Authors:  P Rosenzweig; S Brohier; A Zipfel
Journal:  Br J Clin Pharmacol       Date:  1995-06       Impact factor: 4.335

5.  Increase in body mass index from normal weight to overweight in a cross-sectional sample of healthy research volunteers.

Authors:  Amber B Courville; Meagan DiVito; Lindsay Moyer; Anna Rossinoff; Caitlin Royster; Tricia Psota; Elaine Ayres; Kirsten L Zambell
Journal:  Nutr Res       Date:  2014-10-20       Impact factor: 3.315

6.  Volunteerism and self-selection bias in human positron emission tomography neuroimaging research.

Authors:  Lynn M Oswald; Gary S Wand; Shijun Zhu; Victoria Selby
Journal:  Brain Imaging Behav       Date:  2013-06       Impact factor: 3.978

7.  CT-Screening for lung cancer does not increase the use of anxiolytic or antidepressant medication.

Authors:  Linda Kaerlev; Maria Iachina; Jesper Holst Pedersen; Anders Green; Bente Mertz Nørgård
Journal:  BMC Cancer       Date:  2012-05-23       Impact factor: 4.430

8.  Role of personality traits in reporting the development of adverse drug reactions: a prospective cohort study of the Estonian general population.

Authors:  Anu Realo; Henriët van Middendorp; Liisi Kööts-Ausmees; Jüri Allik; Andrea W M Evers
Journal:  BMJ Open       Date:  2018-07-10       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.